A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules

EMBO Journal

Volumn 17, Issue 11, 1998, Pages 2971-2981

  Kropshofer, Harald ^a   Vogt, Anne B ^a   Thery, Clotilde ^b   Armandola, Elena A ^a   Li, Bi Chen ^a   Moldenhauer, Gerhard ^a   Amigorena, Sebastian ^b   Hämmerling, Günter J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUT CURIE   (France)

Author keywords

Antigen presentation; Chaperone; Editing; HLA DR; Peptide binding

Indexed keywords

CHAPERONE; HLA D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYSOSOME; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY;

EID: 0032101695     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.11.2971     Document Type: Article

References (66)

1. Adams, T.E., Bodmer, J.G. and Bodmer, W.F. (1983) Production and characterization of monoclonal antibodies recognizing the α-chain subunits of human Ia alloantigens. Immunology, 50, 613-624.
2. Amigorena, S., Webster, P., Drake, J., Newcomb, J., Cresswell, P. and Mellman, I. (1995) Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med., 181, 1729-1741.
3. Avva, R. and Cresswell, P. (1994) In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity, 1, 763-774.
4. Bakke, O. and Dobberstein, B. (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell, 63, 707-715.
5. Bijlmakers, M.E., Benaroch, P. and Ploegh, H.L. (1994) Mapping functional regions in the luminal domain of class II-associated invariant chain. J. Exp. Med., 180, 623-629.
6. Denzin, L.K. and Cresswell, P. (1995) HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell, 82, 155-165.
7. Denzin, L.K., Robbins, N.F., Carboy-Newcomb, C. and Cresswell, P. (1994) Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity, 1, 595-606.
8. Denzin, L.K., Hammond, C. and Cresswell, P. (1996) HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med., 184, 2153-2165.
9. Denzin, L.K., Sant'Angelo, D.B., Hammond, C., Surman, M.J. and Cresswell, P. (1997) Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science, 278, 106-109.
10. Douek, D.C. and Altmann, D.M. (1997) HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol., 9, 355-364.
11. Fersht, A. (1985) Enzyme Structure and Mechanism. W.H. Freeman and Company, New York.
12. Fling, S.P., Arp, B. and Pious, D. (1994) The HLA-DMA gene is required for the formation of stable class II/peptide complexes. Nature, 368, 554-558.
13. Frydman, J. and Höhfeld, J. (1997) Chaperones get in touch: the Hip-Hop connection. Trends Biochem. Sci., 22, 87-92.
14. Fung-Leung, W.-P., Surh, C.D., Liljedahl, M., Pang, J., Leturcq, D., Peterson, P.A., Webb, S.R. and Karlsson, L. (1996) Antigen presentation and T cell development in H2-M deficient mice. Science, 271, 1278-1281.
15. Germain, R. and Hendrix., L.R. (1991) MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature, 353, 134-139.
16. Germain, R. and Rinker, A.G., Jr (1993) Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes selective cell surface expression of occupied molecules. Nature, 363, 725-728.
17. Katz, J.F., Stebbins, C., Appella, E. and Sant, A.J. (1996) Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med., 184, 1747-1753.
18. Kenty, G., Martin, W.D., Van Kaer, L. and Bikoff, E.K. (1998) MHC class II expression in double mutant mice lacking invariant chain and DM functions. J. Immunol., 160, 606-614.
19. Kovats, S., Grubin, C.E., Eastman, E., deRoos, P., Dongre, A., Van Kaer, L. and Rudensky, A.Y. (1998) Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo. J. Exp. Med., 187, 245-251.
20. Kropshofer, H., Bohlinger, I., Max, H. and Kalbacher, H. (1991) Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR1 via Trp pockets. Biochemistry, 30, 9177-9187.
21. Kropshofer, H., Vogt, A.B. and Hammerling, G.J. (1995a) Structural features of invariant chain CLIP region controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc. Natl Acad. Sci. USA, 92, 8313-8317.
22. Kropshofer, H., Vogt, A.B., Stern, L.J. and Hammerling, G.J. (1995b) Self-release of CLIP in peptide loading of HLA-DR molecules. Science, 270, 1357-1359.
23. Kropshofer, H., Vogt, A.B., Moldenhauer, G., Hammer, J., Blum, J.S. and Hammerling, G.J. (1996) Editing of the HLA-DR peptide repertoire by HLA-DM. EMBO J., 15, 6144-6154.
24. Kropshofer, H., Hammerling, G.J. and Vogt, A.B. (1997a) How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today, 18, 77-82.
25. Kropshofer, H., Arndt, S.O., Moldenhauer, G., Hämmerling, G.J. and Vogt, A.B. (1997b) HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity, 6, 293-302.
26. Lampson, L.A. and Levy, R. (1980) Two populations of Ia-like molecules on a human B cell line. J. Immunol., 125, 293-299.
27. Liang, M.N., Beeson, C., Mason, C. and McConnell, H.M. (1995) Kinetics of the reaction between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol., 7, 1397-1404.
28. Liljedahl, M., Kuwana, T., Fung-Leung, W.-P., Jackson, M.R., Peterson, P.A. and Karlsson, L. (1996) HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J., 15, 4817-4824.
29. Liljedahl, M. et al. (1998) Altered antigen presentation in mice lacking H2-O. Immunity, 8, 233-243.
30. Lindstedt, R., Liljedahl, M., Péléraux, A., Peterson, P.A. and Karlsson, L. (1995) The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity, 3, 561-572.
31. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V. and Peterson, P.A. (1990) Intracellular transport of class II MHC molecules directed by the invariant chain. Nature, 348, 600-605.
32. Mackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S. and Hercend, T. (1993) Evidence for in situ amplification of cytotoxic T-lymphocytes with anti-tumor activity in a human regressive melanoma. Cancer Res., 53, 3569-3573.
33. Maric, M.A., Taylor, M.D. and Blum, J.S. (1994) Endosomal aspartic proteinases are required for invariant chain processing. Proc. Natl Acad. Sci. USA, 91, 2171-2175.
34. Marks, M.S., Roche, P.A., van Donselaar, E., Woodruff, L., Peters, P.J. and Bonifacino, J.S. (1995) A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J. Cell Biol., 131, 351-369.
35. Martin, W.D., Hicks, G.G., Mendiratta, S.K., Leva, H.I., Ruley, H.E. and van Kaer, L. (1996) H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell, 84, 543-550.
36. Mellins, E., Smith, L., Arp, B., Cotner, T., Celis, E. and Pious, D. (1990) Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature, 343, 71-74.
37. Miyazaki, T., Wolf, P., Tourne, C., Waltzinger, C. Dierich, A., Barois, N., Ploegh, H., Benoist, C. and Mathis, D. (1996) Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell, 84, 531-542.
38. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J. and Mellins, E. (1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature, 368, 551-554.
39. O'Reilly, D.R., Miller, L.K. and Lukow, V.A. (1994) Baculovirus Expression Vectors. A Laboratory Manual. Oxford University Press, New York, NY.
40. Peters, P.J., Neefjes, J.J., Oorschot, V., Ploegh, H.L. and Geuze, H.J. (1991) Segregation of MHC class II molecules from MHC class II molecules in the Golgi complex for transport to lysosomal compartment. Nature, 349, 669-676.
41. Pierre, P., Denzin, L.K., Hammond, C., Drake, J.R., Amigorena, S., Cresswell, P. and Mellman, I. (1996) HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity, 4, 229-239.
42. Rammensee, H.-G., Friede, T. and Stefanovic, S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228.
43. Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A. and Cresswell, P. (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature, 360, 474-477.
44. Roche, P.A. and Cresswell, P. (1990) Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature, 345, 615-618.
45. Sadegh-Nasseri, S. and Germain, R.N. (1991) A role for peptide in determining MHC class II structure. Nature, 353, 167-170.
46. Sanderson, F., Kleijmeer, M., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J., Geuze, H.J. and Trowsdale, J. (1994) Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science, 266, 1566-1569.
47. Sanderson, F., Thomas, C., Neefjes, J. and Trowsdale, J. (1996) Association between HLA-DM and HLA-DR in vivo. Immunity, 4, 87-96.
48. Schafer, P.H., Green, J.M., Malapati, S., Gu, L. and Pierce, S.K. (1996) HLA-DM is present in one-fifth the amount of HLA.DR in the class II peptide loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. J. Immunol. 157, 5487-5495.
49. Servenius, B., Rask, L. and Peterson, P.A. (1987) Class II genes of the human major histocompatibility complex. The DOβ gene is a divergent member of the class II β gene family. J. Biol. Chem., 262, 8754-8766.
50. Sette, A. et al. (1992) Invariant chain peptides in most HLA-DR molecules of an antigen processing mutant. Science, 258, 1801-1804.
51. Sette, A., Southwood, S., Miller, J. and Appella, E. (1995) Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med., 181, 677-683.
52. Sherman, M.A., Weber, D.A. and Jensen, P. (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptides. Immunity, 3, 197-205.
53. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E. and Zaller, D.M. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature, 375, 802-806.
54. Solheim, J.C., Carreno, B.M. and Hansen, T.H. (1997) Are transporters associated with antigen processing (TAP) and tapasin class I MHC chaperones? J. Immunol., 158, 541-543.
55. Swier, K., Brown, D.R., Bird, J.J., Martin, D.W., Van Kaer, L. and Reiner, S.L. (1998) A critical, invariant chain independent role for H2-M in antigen presentation. J. Immunol., 160, 540-544.
56. Takebe, Y., Seiki, M., Fulisawa, J., Hoy, P. Yokota, K., Arai, K., Yoshida, M. and Arai, N. (1988) SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol., 8, 466-472.
57. Tonelle, C., DeMars, R. and Long, E.O. (1985) DOβ: a new β chain gene in HLA-D wih a distinct regulation of expression. EMBO J., 4, 2839-2847.
58. Tourne, S., Miyazaki, T., Wolf, P., Ploegh, H., Benoist, C. and Mathis, D. (1997) Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. Proc. Natl Acad. Sci. USA, 94, 9255-9260.
59. Trowsdale, J. (1995) 'Both man and bird and beast': comparative organization of MHC genes. Immunogenetics, 41, 1-17.
60. Trowsdale, J. and Kelly, A. (1985) The human HLA class II α chain gene DZ α is distinct from gene in the DP, DQ and DR subregions. EMBO J., 4, 2231-2237.
61. Urban, R.G., Chicz, R.M. and Strominger, J.L. (1994) Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J. Exp. Med., 180, 751-755.
62. van Ham, S.M., Grüneberg, U., Malcharek, G., Bröker, I., Melms, A. and Trowsdale, J. (1996) Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med., 184, 2019-2024.
63. van Ham, S.M. et al. (1997) HLA-DO is a negative modulator of HLA-DM mediated MHC class II peptide loading. Curr. Biol., 7, 950-957.
64. Vogt, A.B., Stern, L.J., Amshoff, C., Dobberstein, B., Hämmerling, G.J. and Kropshofer, H. (1995) Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol., 155, 4757-4765.
65. Vogt, A.B., Kropshofer, H., Moldenhauer, G. and Hämmerling, G.J. (1996) Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl Acad. Sci. USA, 93, 9724-9729.
66. Weber, D.A., Evavold, B.D. and Jensen, P.E. (1996) Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science, 274, 618-620.